This is the authors' abstract. We don't add key points for this paper.
Salivary gland cancers represent a rare group of tumors composed by over 20 histological subtypes. Initially treated as one single disease, its diagnosis, prognosis, and treatment are currently being stratified based on morphology. More recently, insight has been provided on the molecular characterization of each subtype, further improving diagnostic accuracy and paving the way for personalized therapy. In this article, we provide a comprehensive review of recent breakthroughs, preliminary results of novel therapy, and future directions on the treatment of these complex malignancies.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Schvartsman et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: